The data published on Disclosure UK today shows that the industry invested £381.2 million on R&D activities in the UK during 2019, up from £377.3 million in 2018.
The ABPI’s consultation on the proposed 2021 Code of Practice is now open and we welcome your feedback.
The COVID-19 pandemic is an unprecedented situation that is constantly changing. To help you understand how the pharmaceutical industry is responding, we answer your questions.
We’re in regular contact, both with our members and the Government about any impact that the coronavirus could have on medicine supply in the UK.
This information is updated regularly, however it does not supersede advice or information provided by the relevant Government bodies and regulators.
The Government has confirmed that COVID-19 testing capacity will increase.
As part of the health community, the life sciences sector in the UK wants to play as big a role as possible in tackling COVD-19.
07 August 2020
The UK has published additional information related to the operation of the Northern Ireland Protocol in a new policy paper, Moving goods under the Northern Ireland Protocol.
04 August 2020
The DHSC has published a letter setting out the government’s plan and requests of industry and the wider supply chain ahead of the end of the Brexit transition period to help ensure the continuity of supply of medical goods into and out of the UK.
29 July 2020
The International Trade Committee has published its report and recommendations into COVID-19 and international trade. The ABPI's Chief Executive had given evidence to the Committee.
20 July 2020
Positive news from early trials of the Oxford coronavirus vaccine indicating that the vaccine generates an immune response has been welcomed by the UK pharmaceutical industry.
18 June 2020
Before the coronavirus pandemic, this Thursday would have been the annual Chwarae Teg Womenspire Awards 2020 - celebrating the achievements of women from all backgrounds and stages in life or work across Wales.
25 May 2020
As Gavi marks its twentieth anniversary, a new report from the ABPI and IFPMA looks at the past successes of the Vaccines Alliance and what the future holds. Richard Torbett looks ahead to that commitment to protect future generations from infectious diseases.